Independent research underscores the superior weight loss efficacy of Eli Lilly's Mounjaro over Novo Nordisk's Ozempic, stirring debate and market...
Soligenix Reports Positive Interim Findings from Investigator-Initiated Study, Highlighting Safety and Efficacy in Real-World Setting Soligenix (SNGX), a late-stage biopharmaceutical...
Balancing Biotech Bets with Emerging Tech and Aerospace Cathie Wood, the visionary behind ARK Investment Management, is known for her...
Investments in Archer Aviation, Recursion Pharmaceuticals, and Intellia Therapeutics Highlight a Shift Towards Innovation Cathie Wood, the visionary Founder and...
FDA Interaction, Upcoming Data, and Strategic Path Forward Viking Therapeutics (VKTX) continues to make significant strides with its promising candidate...
Tesla is one step closer to launching full-self driving (FSD) technology in China Tesla (TSLA) is making significant strides towards...
Potential New Standard Treatment for Advanced ALK-Positive Lung Cancer Pfizer's (PFE) drug Lorbrena has demonstrated promising long-term results in a...
New Implant Technology Offers Hope for Managing Obesity and Diabetes in Cats Vivani Medical (VANI) has announced a significant breakthrough...
$5.3 Billion Expansion to Enhance Supply of Weight Loss and Diabetes Treatments Eli Lilly (LLY) announced a $5.3 billion investment...
GT Biopharma Shares Soar 148% Amid Positive Q1 Updates and Promising Pipeline Developments GT Biopharma Inc. (GTBP) has experienced a...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?